Inventage Lab, Inc. (389470.KQ) has a MoatMap StockRank of 5/100 based on Quality (23/100), Value (34/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.
Inventage Lab, Inc., a platform technology company, develops medicines using microfluidics-based drug delivery systems. The company was founded in 2015 and is based in Seongnam-si, South Korea.
| Price | $28.96 |
| Market Cap | $362M |
| Price/Book | 8.44 |
| Return on Equity | -7.9% |
| Return on Invested Capital | -10.5% |
| Debt/Equity | 66.90 |
| Gross Margin | -128.5% |
| Operating Margin | -2135.2% |
| Revenue Growth | 132.3% |
| Free Cash Flow | $-12K |
Inventage Lab, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).